Form 4: eHealth Director Dale B. Wolf Receives Annual Restricted Stock Units

Director Dale B. Wolf received an annual award of 31,760 restricted stock units (RSUs) from eHealth, Inc. on June 11, 2024, vesting quarterly.

Summary

• Dale B. Wolf, a director at eHealth, Inc., received 31,760 restricted stock units (RSUs) on June 11, 2024.
• These RSUs represent a contingent right to receive one share of eHealth's common stock upon vesting.
• The RSUs vest in four equal quarterly installments starting from June 11, 2024, contingent upon continued service.
• Unvested RSUs will fully vest prior to the next annual stockholder meeting or upon a Change in Control, subject to continued service.
• Wolf directly owns 108,559 shares of eHealth common stock and indirectly owns 62,932 shares through the Dale B. Wolf Generation Skipping Trust.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of equity compensation for directors, indicating a stable and ongoing relationship between the director and the company. The sentiment is neutral to positive.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.
• The accelerated vesting upon a Change in Control provides additional security and incentive.

Risks

• The value of the RSUs is dependent on the future performance of eHealth's stock.
• The vesting is contingent upon continued service, so any departure from the company would result in forfeiture of unvested RSUs.

Future Outlook

The document does not contain specific forward-looking statements, but the RSU grant suggests an expectation of continued service and contribution from the director.

Industry Context

Grants of restricted stock units to directors are a common practice in publicly traded companies to align their interests with those of shareholders and incentivize long-term value creation.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of shareholders, potentially leading to decisions that benefit shareholder value.
• The vesting schedule incentivizes the director to remain with the company, providing stability and experience to the board.

Key Dates